Jay-Fei Cheng

Title: Jay-Fei Cheng: Innovator in Antimicrobial Compounds

Introduction

Jay-Fei Cheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial compounds. With a total of 2 patents, Cheng's work is recognized for its potential impact on public health.

Latest Patents

Cheng's latest patents focus on quinolone compounds. The first patent presents a compound represented by a specific formula, where X can be a hydrogen atom or a fluorine atom. The compound includes various substituents, such as cyclopropyl or phenyl groups, and demonstrates excellent antimicrobial activity. This compound is particularly useful for preventing or treating intestinal infections, including diarrhea. The second patent mirrors the first, emphasizing the same innovative aspects and applications of the quinolone compound.

Career Highlights

Jay-Fei Cheng is currently employed at Otsuka Pharmaceutical Company, Limited. His role at the company allows him to leverage his expertise in pharmaceutical research and development. Cheng's innovative work has positioned him as a key figure in the advancement of antimicrobial therapies.

Collaborations

Cheng collaborates with notable colleagues, including Mamuti Abudusaimi and Fangguo Ye. These partnerships enhance the research and development efforts within their projects, fostering a collaborative environment that drives innovation.

Conclusion

Jay-Fei Cheng's contributions to the field of antimicrobial compounds highlight his role as an influential inventor. His patents reflect a commitment to improving health outcomes through innovative pharmaceutical solutions.